
Electronic death registration is a win-win for SA — let's make it happen
Several studies have flagged problems with South Africa's death registration processes. To address it, a critical first step is to replace our paper-based process with an electronic one.
A recent report by the South African Medical Research Council (SAMRC) highlights the underreporting of HIV in official mortality statistics.
Official cause of death statistics are based on what doctors write on death notification forms. As part of the process of death registration, medical practitioners are required by law to provide information about the medical conditions resulting in each death. Multiple studies have identified concerns about the quality of the information provided by doctors and the Department of Health has been urged in a policy brief to address them as it clearly undermines the quality of data used by our government for health planning and resource allocation.
The recently reported study found extensive underreporting of HIV as a cause of death. Only 28% of deaths that occurred in a national sample of public sector hospitals where the medical record had clear clinical indications of HIV, had HIV specified on their death notification form.
Aside from ensuring that medical certification of the cause of death is part of the medical training curriculum, and that additional training is provided during internship periods, another key issue to address is that many doctors are reluctant to record HIV/Aids as a cause of death due to concerns about maintaining patient confidentiality. In 2014, a self-sealing section was added to protect information about cause of death on the death notification form, but this has clearly not had the desired effect.
Following the deaths of at least 22 children from contaminated food in 2024, President Cyril Ramaphosa announced that the Department of Health would develop an electronic system for recording causes of death as one of several responses to the emergency. The move to an electronic system offers a strategic opportunity to address the challenge around confidentiality and promises a lot more. It allows for secure, institution-based data management that protects confidentiality, encourages accurate reporting and strengthens the integrity of vital statistics.
Benefits of this digital transition will include:
Improved data quality and confidentiality, encouraging accurate reporting of sensitive conditions like HIV/Aids;
Automated validation checks, reducing certification errors at the point of data entry;
Real-time access to mortality data, enabling rapid public health responses; and
A platform for quality assurance and feedback, currently not possible in the paper-based system.
Ultimately, moving away from a paper-based process of death registration will reduce the administrative burden and improve efficiency across the system. This presents a timely and valuable opportunity to collaborate across departments, including health, home affairs and Statistics South Africa, to modernise the country's civil registration and vital statistics system.
We are at a pivotal moment for such coordinated policy action. Investing in a robust electronic system for cause-of-death certification will strengthen South Africa's public health planning, improve disease surveillance and increase accountability. The long-term returns – through faster, more reliable data – are substantial for both governance and health outcomes. It is a win-win. DM
Dr Pam Groenewald and Professor Debbie Bradshaw are with the South African Medical Research Council's Burden of Disease Research Unit.
Note: Spotlight previously reported on the issues discussed in this opinion piece. That reporting included the sentence: 'In the meantime, routine mortality data from Stats SA should clearly be taken with a pinch of salt.' That sentence may have been construed as reflecting Groenewald and the SAMRC's views. Groenewald has asked us to clarify that it does not. She points out that Stats SA is obligated to process the data it receives and the quality issues stem from what doctors report.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Eyewitness News
4 hours ago
- Eyewitness News
Deputy minister Andrew Whitfield possibly axed for defying travel protocol
Tshidi Madia and Mbali Dhlamini 26 June 2025 | 13:00 Andrew Whitfield Cyril Ramaphosa FILE: Andrew Whitfield during his time as deputy minister of trade, industry and competition. Picture: @the_dtic/X JOHANNESBURG - President Cyril Ramaphosa's office has remained silent on the sudden removal of DA politician Andrew Whitfield from his role as one of the deputy ministers at Trade, Industry and Competition. Eyewitness News understands that Whitfield's dismissal may be linked to insubordination over a DA-led trip to Washington undertaken without the President's approval. Earlier, Ramaphosa's office confirmed the removal, saying this was not an indication of a wholesale cabinet reshuffle. History of similar dismissals Winnie Madikizela-Mandela was fired by South Africa's founding president, Nelson Mandela, in 1995, one of the reasons was that she took an unauthorised personal trip abroad. In 2007, President Thabo Mbeki, Mandela's successor, also dismissed then Deputy Health Minister Nozizwe Madlala-Routledge after she attended an HIV/Aids conference in Madrid without his permission. Fast forward to 2025, and the DA's Andrew Whitfield suffers the same fate. On his part, it's a trip to the US in March without President Cyril Ramaphosa's authorisation that did him in. Several government insiders have told Eyewitness News that even when travel is in one's private capacity, permission must be sought As the DA enters an emergency federal council meeting, some of its Cabinet members are fuming, accusing the president and his party of abuse. DA leader John Steenhuisen has lashed out at Ramaphosa for firing Whitfield. Steenhuisen was in Parliament on Thursday afternoon, where the Revenue Bill is under discussion. He used his time in parliament to address the developments of this afternoon, which saw a DA member axed from a top post. Steenhuisen says Whitfield was dismissed for a very flimsy offence.


Eyewitness News
4 hours ago
- Eyewitness News
DA threatens no confidence motion against Ramaphosa if he fails to step up fight against corruption
CAPE TOWN - The Democratic Alliance (DA) is threatening a motion of no confidence in President Cyril Ramaphosa if he doesn't step up against corruption. As the party's 48-hour ultimatum deadline ran out on Saturday for Ramaphosa to act against ANC ministers accused of corruption, the DA announced it would opt out of the national dialogue. ALSO READ: The much-vaunted dialogue, which aims to set a policy direction for the government of national unity (GNU), is set to start in August after several delays. But the DA says if it includes corrupt ANC MPs, it will be nothing more than an electioneering ploy ahead of next year's local government elections. DA leader John Steenhuisen says Ramaphosa doesn't enjoy unfettered executive powers having been put in that position on the back of his party's good faith. And it expects him to live up to his promise to clean house, starting in front of his own doorstep. "The people of South Africa voted for change. They did not vote for more of the same. They did not vote for more of the Zuma years where the corrupt and those responsible for maladministration are shielded and protected." Steenhuisen is again putting Ramaphosa on terms, saying if he doesn't act against questionable ministers, it will act against him. "It is clear that the DA is in the process of losing confidence in the president's ability to act as a leader, not only of the ANC, but of the GNU of which we are the second largest component." In the meantime, the DA says it will be rejecting the budget votes of departments where corruption-accused ministers are at the helm, imperilling the final hurdle of the budget process, which starts this week.


The Citizen
7 hours ago
- The Citizen
Fact-checked: HIV/Aids breakthrough not a ‘cure', popular social media posts misrepresent the facts
While promising, a recent breakthrough in HIV research is not a 'cure' or a 'vaccine', as several posts claim on social media. The scientists involved say it could be many years before the technology is used as a cure. Users on Facebook, Instagram and X have shared the same 'BREAKING NEWS' message, claiming that 'A CURE FOR HIV/AIDS HAS JUST BEEN FOUND'. Africa Check found hundreds of these posts, the most popular of which have been viewed millions of times. The message is typically accompanied by a graphic which includes the text 'Researchers in Australia have just found a cure for HIV/Aids' and an image created using artificial intelligence tools, of a bottle labelled 'HIV Vaccine®'. Unfortunately, this claim is not true. The human immunodeficiency virus, or HIV, is a virus which attacks the immune system, the processes responsible for protecting the body from disease. If left untreated, it causes acquired immunodeficiency syndrome, or Aids. HIV can be treated with antiretroviral drugs, which prevent the virus from multiplying in a person's body. ARV treatment can lower the level of the virus in a person's body to the point that it is undetectable and cannot be transmitted to others. However, ARVs cannot eradicate the virus entirely. So what has prompted these 'breaking news' posts? In this case, there is a real scientific breakthrough behind these claims, but it has been described in a misleading way. Deliberately misleading headline and image shared alongside text copied from genuine news story These posts include paragraphs of text, describing the scientific breakthrough. They begin: A cure for HIV could be a step closer after researchers found a new way to force the virus out of hiding inside human cells. The virus's ability to conceal itself inside certain white blood cells has been one of the main challenges for scientists looking for a cure. It means there is a reservoir of the HIV in the body, capable of reactivation, that neither the immune system nor drugs can tackle. Now researchers from the Peter Doherty Institute for Infection and Immunity in Melbourne, have demonstrated a way to make the virus visible, paving the way to fully clear it from the body. The text is identical to the first 12 paragraphs of a news article published by the UK's Guardian newspaper on 5 June 2025. None of the posts which Africa Check found clearly credited the Guardian as the source, nor did they include the entire article. The original article is headlined: 'Breakthrough in search for HIV cure leaves researchers 'overwhelmed'.' In the posts on social media this has been replaced, usually with a variation on 'Breaking News: A cure for HIV/Aids has just been found', sometimes misspelling Aids as 'Auds'. The Guardian article never refers to the research as a 'cure', but only as a promising step towards one. In sections of the article not included in the social media posts, researchers are quoted as being 'very hopeful' that the breakthrough could eventually be replicated in humans. But this could be a long way off. The Guardian notes: 'The path to using the technology as part of a cure for patients is long and would require successful tests in animals followed by safety trials in humans, likely to take years, before efficacy trials could even begin.' The Guardian links back to the original scientific paper, published in the journal Nature Communications. The paper also does not refer to its findings as a 'cure' for HIV. Although they don't represent a 'cure', the findings are a promising development in HIV research. Promising advancement in research, not HIV cure As already discussed, ARV medications can reduce the presence of HIV in a person's body, but not eradicate the virus entirely. The Nature Communications article covers research into a potential solution to this problem. In their paper and in comments to the Guardian, the University of Melbourne researchers describe a new method of delivering genetic material, known as mRNA, into certain kinds of white blood cells. HIV is able to infect these white blood cells, where it can essentially hide from the body's immune system and other forms of treatment. Being able to reach the virus inside those white blood cells opens up new opportunities to treat it. Vaccines against Covid-19 also made use of mRNA, which may be why the graphic accompanying these 'HIV cure' claims depicts an 'HIV vaccine'. (The image in the graphic is very similar to stock images that have existed since 2016.) The Nature Communications study did not use mRNA to vaccinate against HIV, but demonstrated that 'therapeutic mRNA', such as small pieces of mRNA designed to alert the immune system to the presence of the virus, could be delivered to these white blood cells. At time of writing, there is no cure for HIV/Aids. But besides this breakthrough, there have been other promising developments in HIV treatment. Real breakthroughs in HIV treatment In 2023, a clinical trial began in South Africa and the US to test the efficacy of a potential vaccine against HIV called VIR-1388. Like other vaccines, VIR-1388 would not be a cure for HIV but, if it works, may prevent infection and therefore stop the spread of the disease. It was developed by US-based Vir Biotechnology. ARVs can be taken as pre-exposure prophylaxis, or PrEP, by people who are HIV negative but likely to be exposed to the virus. This can prevent transmission of HIV. However, PrEP must be taken frequently to ensure proper protection. Current South African PrEP guidelines involve taking one pill every day. Lenacapavir is an injectable drug which has been shown to reliably protect against HIV transmission for six months at a time, with some trials demonstrating protection for a full year. After successful trials, there are plans to begin use of the drug in countries such as South Africa, which has a particularly high burden of HIV. It has been approved for use in the US. Like other forms of PrEP, Lenacapavir is neither a 'cure' nor a 'vaccine', but can prevent HIV transmission. Because it is much longer lasting than other forms of PrEP, it may make it much easier to prevent transmission.